Aurigene Pharmaceutical Signs Long-Term Manufacturing Pact with Global Pharma Firm
Aurigene Pharmaceutical Services, a subsidiary of Dr. Reddy's Laboratories, has signed a long-term manufacturing and supply agreement with an undisclosed global pharmaceutical company. The deal covers over 20 products including sterile injectables, biologics, and topicals, targeting markets in the US, Europe, Canada, and emerging regions. The partnership involves phased technology transfer over two to three years, with commercial manufacturing and supply expected to start by 2028, aiming for annual volumes of approximately 18 million units.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (70/100). Lens Score 37/100.
Outlets measured: thehindu, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (65–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 25 Aug, 10:33 am. Other outlets followed.
- 1